Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation.
We analyzed karyotype stability in 22 patients with acute leukemia at relapse or disease progression after allogeneic stem cell transplantation (allo-SCT). Karyotypes before and at relapse after allo-SCT were different in 15 patients (68%), the most frequent type being clonal evolution either alone or combined with clonal devolution (13 patients). Patients with and without a karyotype change did not differ significantly in overall survival (OS) (median, 399 vs. 452 days; P = 0.889) and survival after relapse (median, 120 vs. 370 days; P = 0.923). However, acquisition of additional structural chromosome 1 abnormalities at relapse after allo-SCT occurred more frequently than expected and was associated with reduced OS (median, 125 vs. 478 days; P = 0.008) and shorter survival after relapse (median, 37 vs. 370 days; P = 0.002). We identified a previously undescribed clonal evolution involving t(15;17) without PML-RARA rearrangement in an AML patient. We conclude that a karyotype change is common at relapse after allo-SCT in acute leukemia patients. Moreover, our data suggest that additional structural chromosome 1 abnormalities are overrepresented at relapse after allo-SCT in these patients and, in contrast to a karyotype change per se, are associated with reduced OS and shorter survival after relapse.
Schmidt-Hieber
Martin
M
Medical Department III (Hematology, Oncology and Transfusion Medicine), Charité Campus Benjamin Franklin, 12200 Berlin, Germany. martin.schmidt-hieber@charite.de
Blau
Igor W
IW
Richter
Gregor
G
Türkmen
Seval
S
Bommer
Christiane
C
Thiel
Gundula
G
Neitzel
Heidemarie
H
Stroux
Andrea
A
Uharek
Lutz
L
Thiel
Eckhard
E
Blau
Olga
O
D000328:Adult; D000368:Aged; D002877:Chromosomes, Human; D002999:Clone Cells / Q000473:pathology; D020732:Cytogenetic Analysis / Q000379:methods; D018450:Disease Progression; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D015470:Leukemia, Myeloid, Acute / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D012008:Recurrence; D033581:Stem Cell Transplantation / Q000379:methods; D014184:Transplantation, Homologous; D055815:Young Adult